Please provide your email address to receive an email when new articles are posted on . Nephrectomy can be effectively performed in patients with autosomal dominant PKD for various indications, such ...

Clinicopathological features and prognosis of MED15-TFE3 rearrangement renal cell carcinoma: An updated report. Updated outcomes of patients with metastatic non-clear cell renal cell carcinoma ...

Nephron-sparing surgery may not reduce the risk for later kidney failure in patients with kidney cancer and stage 4 CKD. Despite the promise of nephron-sparing, new study findings suggest that the ...

University of Iowa Health announced in early February 2026 that it had successfully completed its first robotic living donor nephrectomy ...

In a study, partial nephrectomy was associated with a 66% lower risk for stage 4 or higher CKD versus radical nephrectomy. Kidney cancer patients have a lower risk of developing stage 4 or higher ...

Banner University Medicine Tucson has reached a milestone by completing its first robotic-assisted living donor nephrectomy.

Feb. 19, 2004 — Adjuvant treatment with autologous renal tumor cell vaccine seems to be beneficial in patients with organ-confined renal cell carcinoma, according to the results of a phase III, ...

University of Iowa Health Care transplant surgeon Ramy El-Diwany recently performed the first robotic living donor ...

Adding belzutifan to pembrolizumab after kidney cancer surgery cuts recurrence risk by 28%, helping high-risk patients stay ...

PN and RFA offer similar survival for cT1a RCC tumors ≤2 cm, but PN is superior for larger tumors. RFA may be considered for elderly patients with comorbidities, especially for tumors ≤2 cm. PN ...

A large national study in Denmark following nearly 1,900 patients over almost a decade has found that a minimally invasive ...